CLINICAL MEDICAL REAGENTS BIOLOGICAL

Brand Owner Address Description
GLYCOFECTION I.D.M. IMMUNO-DESIGNED MOLECULES 172, rue de Charonne F-75011 PARIS France clinical medical reagents and biological tissue intended for subsequent implantation to human body parts;biochemicals, namely precursors of in vitro engineering use, reagents for scientific or medical research use;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method and apparatus are provided for adjusting a dynamic range of a digital medical image for a medical imaging system. The digital medical image contains a clinical region and a non-clinical region. The method and apparatus identify the non-clinical region of the digital medical image and mask the non-clinical region therefrom to form a clinical image. The clinical image is then used to calculate a desired dynamic range for the medical imaging system. The dynamic range of the medical imaging system is adjusted accordingly. According to one embodiment, the non-clinical region is identified by dividing the digital medical image into bands of a predetermined width, generating profiles for each band and differentiating the profiles to obtain a differentiated profile of each band of a digital medical image. The differentiated profile is than analyzed to identify peaks that exceed predetermined thresholds, wherein the regions of the differentiated profile proximate the peaks exceeding the threshold correspond to non-clinical regions. Once the non-clinical regions are identified, they are masked or removed. Next, a desired image characteristic, such as maximum and minimum gray scale values, are determined for the clinical region and a desired dynamic range for the image is obtained based on the image characteristics of the clinical region. In an alternative embodiment, a histogram is used to identify the non-clinical regions which are subsequently masked from the digital medical image.